Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: COG ANBL0032 Principal Investigator: Wilson, David
Title: Phase III Randomized Study of Chimeric anti-GD2 in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
Phase: III Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
To determine if monoclonal antibody CH14.18 + cytokines + 13 cis-RA improved event free and overall survival after myeloablative therapy and stem cell rescue as compared to RA alone.
 
More Information:
Internal Protocol Documents (requires Siteman administrative database password)